| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2022 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 41 | $12.32 | $505.12 | - | +90.0% | +51.4% | |
| May 13, 2022 | DCTH Delcath Systems, Inc. | Salamon Steven A J50 | Director | Buy | 5,000 | $5.03 | $25,135.00 | +1.1% | -6.8% | +24.3% | |
| May 13, 2022 | SONX Sonendo, Inc. | Pudipeddi Vamsi Mohan Raj | Director | Buy | 50,000 | $2.65 | $132,500.00 | New | - | - | |
| May 13, 2022 | SONX Sonendo, Inc. | Watts Michael Patrick | Chief Financial Officer | Sell | 2,129 | $2.78 | $5,916.70 | -0.9% | - | - | |
| May 13, 2022 | SONX Sonendo, Inc. | Smith Michael John | Chief Commercial Officer | Sell | 1,958 | $2.78 | $5,441.48 | -0.6% | - | - | |
| May 13, 2022 | ESTA Establishment Labs Holdings Inc. | Jw Asset Management, LLC61 | 10% Owner | Buy | 5,000 | $54.83 | $274,150.00 | +0.2% | +15.5% | +20.0% | |
| May 13, 2022 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 108 | $12.32 | $1,330.56 | - | +90.0% | +51.4% | |
| May 13, 2022 | AHCO Adapthealth Corp. | Skyknight Capital Fund Ii, L.P.53 | Director | Buy | 180,154 | $15.59 | $2,809,119.23 | +2.4% | +42.7% | -34.8% | |
| May 13, 2022 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 156,751 | $1.83 | $287,081.76 | +2.3% | +18.2% | -8.0% | |
| May 13, 2022 | KRMD Koru Medical Systems, Inc. | Manko Joseph M. Jr.74 | Director, 10% Owner | Buy | 40,000 | $2.08 | $83,072.00 | +0.3% | +19.6% | +89.5% | |
| May 13, 2022 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Sell | 44,200 | $3.81 | $168,605.16 | -1.7% | +10.7% | -49.1% | |
| May 13, 2022 | KRMD Koru Medical Systems, Inc. | Tharby Linda M62 | President And CEO | Buy | 10,197 | $2.19 | $22,325.89 | +0.5% | +19.6% | +89.5% | |
| May 12, 2022 | ICUI Icu Medical Inc/de | Lopez George A45 | Director | Buy | 25,835 | $172.91 | $4,467,255.76 | +1.9% | -1.8% | +15.0% | |
| May 12, 2022 | DCTH Delcath Systems, Inc. | Salamon Steven A J50 | Director | Buy | 6,000 | $4.90 | $29,424.00 | +25.6% | -7.2% | +27.8% | |
| May 12, 2022 | SSKN Strata Skin Sciences, Inc. | Lesovitz Christopher | Chief Financial Officer | Buy | 23,131 | $1.12 | $25,906.72 | New | +3.7% | -4.6% | |
| May 12, 2022 | ICUI Icu Medical Inc/de | Sanzone Virginia Ruth64 | VP, General Counsel | Sell | 750 | $173.56 | $130,170.00 | -18.2% | -1.8% | +15.0% | |
| May 12, 2022 | ICUI Icu Medical Inc/de | Finney Elisha W66 | Director | Sell | 217 | $170.53 | $37,005.01 | -10.1% | -1.8% | +15.0% | |
| May 11, 2022 | CTSO Cytosorbents Corp | Sobel Alan D. | Director | Buy | 10,000 | $2.02 | $20,174.80 | +7.2% | -4.6% | +70.6% | |
| May 11, 2022 | UTMD Utah Medical Products Inc | Payne Barbara A51 | Director | Sell | 2,000 | $85.20 | $170,396.60 | -27.3% | +6.7% | +8.7% | |
| May 11, 2022 | BRKR Bruker Corp | Laukien Frank H65 | President &CEO | Buy | 1,710 | $57.64 | $98,559.27 | - | +6.0% | +34.7% | |
| May 11, 2022 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Buy | 121,646 | $2.14 | $260,017.44 | +1.9% | +103.8% | +31.3% | |
| May 11, 2022 | NVCR Novocure Ltd | Benaim Ely73 | Chief Medical Officer | Sell | 4,205 | $63.17 | $265,645.81 | -5.5% | +32.5% | +26.3% | |
| May 11, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 15,000 | $9.16 | $137,350.00 | +0.1% | +0.8% | +15.8% | |
| May 11, 2022 | RVP Retractable Technologies Inc | Leonard Braden Michael60 | - | Buy | 73,464 | $3.83 | $281,043.70 | +0.7% | +24.0% | -59.0% | |
| May 10, 2022 | BLCO Bausch & Lomb Corp | Bausch Health Companies Inc. | 10% Owner | Sell | 35,000,000 | $17.06 | $596,925,000.00 | -10.0% | -11.7% | +4.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.